Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Novel Diabetes Pill From AstraZeneca, Bristol May Have New Risk
Novel Diabetes Pill From AstraZeneca, Bristol May Have New Risk
Novel Diabetes Pill From AstraZeneca, Bristol May Have New Risk
Submitted by
admin
on October 1, 2009 - 7:30am
Source:
Bloomberg
News Tags:
diabetes
AstraZeneca
Dapagliflozin
Bristol-Myers Squibb
Headline:
Novel Diabetes Pill From AstraZeneca, Bristol May Have New Risk
Do Not Allow Advertisers to Use My Personal information
